SPECIFIC SEROTHERAPY AND CHEMOTHERAPY OF THE PNEUMOCOCCUS PNEUMONIAS
Authors: Maxwell Finland, William C. Spring, Francis C. Lowell, John W. Brown
Journal: Annals of Internal Medicine (1939)

Article1 May 1939SPECIFIC SEROTHERAPY AND CHEMOTHERAPY OF THE PNEUMOCOCCUS PNEUMONIASMAXWELL FINLAND, F.A.C.P., WILLIAM C. SPRING JR., FRANCIS C. LOWELL, JOHN W. BROWNMAXWELL FINLAND, F.A.C.P.Search for more papers by this author, WILLIAM C. SPRING JR.Search for more papers by this author, FRANCIS C. LOWELLSearch for more papers by this author, JOHN W. BROWNSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-12-11-1816 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAdvances in the therapy of pneumonia have been occurring in recent years at an ever-accelerating pace. Nearly three decades elapsed from the earliest recognition of the etiological relationship of the pneumococcus to pneumonia in man and its first successful therapeutic application in specific serum treatment. This first step in the specific therapy of pneumonia was made possible through the subdivision of pneumococci into specific types. Therapy then became available for the most common of these types, namely, Type I. From the earliest use of specific antipneumococcus horse serums in the treatment of pneumococcus Type I pneumonia, it was recognized that,...References1. HEINTZELMANHADLEYMELLON JHPBRR: The use of p-aminobenzenesulphonamide in type 3 pneumococcus pneumonia, Am. Jr. Med. Sci., 1937, cxciii, 759-763. CrossrefGoogle Scholar2. SADUSK JF: Observations on sulfanilamide therapy in pneumonia and meningitis due to Type 3 pneumococci, New Eng. Jr. Med., 1930, ccxix, 787-790. Google Scholar3. FINLANDBROWN MJW: Immunological studies in patients with pneumococcus Type III pneumonia treated with sulfanilamide and serum, Jr. Clin. Invest., 1938, xviii, 309-317. Google Scholar4. PRICEMYERS AEGB: Treatment of pneumococcic pneumonia with sulfanilamide, Jr. Am. Med. Assoc., 1939, cxii, 1021-1027. CrossrefGoogle Scholar5. EVANSGAISFORD GMWF: Treatment of pneumonia with 2-(p-aminobenzenesulfonamido) pyridine, Lancet, 1938, ii, 14-19. AGRANAT, A. L., DREOSTI, A. O., and ORDMAN, D.: Treatment of pneumonia with 2-(p-aminobenzenesulphonamido) pyridine (M. & B. 693), Lancet, 1939, i, 309-317, 380-384. ANDERSON, T. F., and DOWDESWELL, R. M.: Treatment of pneumonia with M. & B. 693, Lancet, 1939, i, 252-254. CrossrefGoogle Scholar6. BARNETTHARTMANNPERLEYRUHOFF HLAFAMMB: The treatment of pneumococcic infections in infants and children with sulfapyridine, Jr. Am. Med. Assoc., 1939, cxii, 518-527. FLIPPIN, H. F., LOCKWOOD, J. S., PEPPER, D. S., and SCHWARTZ, L.: The treatment of pneumococcic pneumonia with sulfapyridine. A progress report on observations in 100 cases, Jr. Am. Med. Assoc., 1939, cxii, 529-534. CrossrefGoogle Scholar7. FINLANDBROWN MJW(a) : Specific treatment of Pneumococcus I pneumonia, Am. Jr. Med. Sci., 1939, cxcvii, 151-168. (b) BROWN, J. W., and FINLAND, M.: Specific treatment of pneumococcus Type II pneumonia, Am. Jr. Med. Sci., 1939, cxcvii, 369-381. (c) FINLAND, M., and BROWN, J. W.: Treatment of pneumococcus Type 3 pneumonia with specific serum and sulfanilamide, New Eng. Jr. Med., 1939, ccxx, 365-372. (d) FINLAND, M., and BROWN, J. W.: Specific treatment of pneumococcus Type V and Type VII pneumonias, Am. Jr. Med. Sci., 1939, cxcvii, 381-393. CrossrefGoogle Scholar8. TILGHMANFINLAND RCM: Clinical significance of bacteremia in pneumococcic pneumonia, Arch. Int. Med., 1937, lix, 602-619. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Presented at the 23rd Annual Session of the American College of Physicians, New Orleans, Louisiana, March 30, 1939.From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School, Boston, Mass. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySynergism between specific immune globulin and antibiotics in therapy of experimental blastomycosisThe Treatment of Pulmonary Infections with Sulfanilamide, Sulfapyridine, and Sulfathiazole 1 May 1939Volume 12, Issue 11Page: 1816-1829KeywordsChemotherapyHospital medicineMedical servicesPneumococcusPneumoniaResearch laboratoriesSerotherapy Issue Published: 1 May 1939 PDF downloadLoading ...